Tybourne Capital Management (Hk) LTD Forte Biosciences, Inc. Transaction History
Tybourne Capital Management (Hk) LTD
- $398 Million
- Q2 2024
A detailed history of Tybourne Capital Management (Hk) LTD transactions in Forte Biosciences, Inc. stock. As of the latest transaction made, Tybourne Capital Management (Hk) LTD holds 3,624,548 shares of FBRX stock, worth $21 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
3,624,548
Previous 3,624,548
-0.0%
Holding current value
$21 Million
Previous $2.54 Million
22.86%
% of portfolio
0.49%
Previous 0.57%
Shares
1 transactions
Others Institutions Holding FBRX
# of Institutions
33Shares Held
19MCall Options Held
3.1KPut Options Held
0-
Perceptive Advisors LLC New York, NY3.27MShares$18.9 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$17.3 Million0.05% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$11.8 Million1.15% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$10.7 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.81MShares$10.5 Million0.0% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $118M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.